Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 06 Jan 2025

Glycyrrhizin as a potential disease-modifying therapy for epilepsy: insights into targeting pyroptosis to exert neuroprotective and anticonvulsant effects

in Inflammation Pharmacology

Lei Wei
Sijie Ou
Youshi Meng
Lanfeng Sun
Lin Zhang
Yuling Lu
Yuan Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530735

2,553 views
5 citations

Original Research

Published on 24 Dec 2024

Bacteroides fragilis capsular polysaccharide A ameliorates ulcerative colitis in rat by recovering intestinal barrier integrity and restoring gut microbiota

in Inflammation Pharmacology

Yijia Zhong
Xiujuan Chang
Zihan Zhao
Lijun Zheng
Gaobo Kuang
Ping Li
Chenxuexuan Liu
Yuqin Fan
Zhixuan Liang
Ke Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402465

4,996 views
10 citations

Review

Published on 23 Dec 2024

Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention

in Inflammation Pharmacology

Annalisa Contursi
Stefania Tacconelli
Sara Di Berardino
Alessandra De Michele
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520488

6,747 views
15 citations

Original Research

Published on 23 Dec 2024

Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments

in Inflammation Pharmacology

Xuanlin Zhao
Fan Li
Ao Wen
Xiuxian Yu
Xinrui Xu
Chengyu Wan
Yu Cao
Guang Xin
Wen Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485915

2,819 views
2 citations

Original Research

Published on 20 Dec 2024

The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses

in Inflammation Pharmacology

Anastasiia Kiprina
Tom Teichmann
Virna Margarita Martín Giménez
Wenqing Xu
Fiona Sailer
Maike Windbergs
Walter Manucha
Andreas Weigert
Ralf P. Brandes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528759

2,688 views
1 citation

Original Research

Published on 19 Dec 2024

Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

in Inflammation Pharmacology

Yiping Cao
Zhou Wu
Moruo Zhang
Ran Ji
Hongxing Zhang
Lingzhen Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467305

2,430 views
3 citations

Correction

Published on 16 Dec 2024

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

in Inflammation Pharmacology

Jing Lu
Jie Gao
Jing Sun
Haiping Wang
Huijuan Sun
Qian Huang
Yao Zhang
Shuo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532774

1,155 views
1 citation

Review

Published on 12 Dec 2024

The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment

in Inflammation Pharmacology

Qianyu Guo
Jie Li
Juanjuan Wang
Linxin Li
Jia Wei
Liyun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502298

8,614 views
5 citations

Review

Published on 06 Dec 2024

Decoding ferroptosis: transforming orthopedic disease management

in Inflammation Pharmacology

Guanlin Huo
Yumeng Lin
Lusheng Liu
Yuqi He
Yi Qu
Yang Liu
Renhe Zhu
Bo Wang
Qing Gong
Zhongyu Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509172

6,006 views
9 citations

Review

Published on 04 Dec 2024

New insights into SUMOylation and NEDDylation in fibrosis

in Inflammation Pharmacology

Jin Han
Jun Wu
Wen-Tao Kou
Li-Na Xie
Ya-Li Tang
Da-Long Zhi
Ping Li
Dan-Qian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476699

3,945 views
6 citations

Editorial

Published on 04 Dec 2024

Editorial: Recent advances in the pathogenesis and potential biomarkers of fibrosis

in Inflammation Pharmacology

Samar A. Antar
Aymen Halouani
Karim Tawfic
Walied Abdo
Ayman M. Mahmoud
Yassine Sassi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527123

1,260 views

Original Research

Published on 26 Nov 2024

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

in Inflammation Pharmacology

Alessandra Ammazzalorso
Stefania Tacconelli
Annalisa Contursi
Ulrika Hofling
Carmen Cerchia
Sara Di Berardino
Alessandra De Michele
Rosa Amoroso
Antonio Lavecchia
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488722

2,936 views
1 citation

Original Research

Published on 21 Nov 2024

Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid

in Inflammation Pharmacology

Caijuan Dong
Jielu Liu
Alessandro Quaranta
Xu Jing
Mu Nie
Craig E. Wheelock
Benjamin Murrell
Jonathan M. Coquet
Tim Melander Bowden
Thomas Engstrand

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503648

2,586 views
1 citation

Correction

Published on 08 Nov 2024

Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

in Inflammation Pharmacology

Huixia Liu
Yue Chen
Huan Wang
Xinyi Luo
Dengpiao Xie
Qing Ji
Li Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404434

1,542 views
1 citation

Review

Published on 07 Nov 2024

Estrogen: the forgotten player in metaflammation

in Inflammation Pharmacology

Bao-Ting Zhu
Qing-Qing Liao
Hai-Ying Tian
Dao-Jiang Yu
Teng Xie
Xi-Lu Sun
Xin-Meng Zhou
Ying-Xuan Han
Yu-Jie Zhao
Mohamed El-Kassas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1478819

6,373 views
12 citations

Review

Published on 06 Nov 2024

P4HA1: an important target for treating fibrosis related diseases and cancer

in Inflammation Pharmacology

Xuewen Yang
Dong Zhang
Mengmeng Li
Yingchun Shao
Xiyang Zhang
Yongzhi Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493420

5,881 views
4 citations

Review

Published on 05 Nov 2024

The impact of diabetes mellitus on tendon pathology: a review

in Inflammation Pharmacology

Jian Xu
Jinbo Wang
Yuncong Ji
Yanlong Liu
Jishi Jiang
Yanbo Wang
Xilong Cui
Yunpeng Wan
Biao Guo
Haiyang Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491633

7,303 views
11 citations

Editorial

Published on 31 Oct 2024

Editorial: Chronic pain: what is the mechanism?

in Inflammation Pharmacology

James David Adams
Ching-Liang Hsieh
Roberta Gualdani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496510

1,491 views

Case Report

Published on 30 Oct 2024

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

in Inflammation Pharmacology

Gui-Chen Ling
Chang Su
Ying-Ao Guo
Xia Qiu
Jia-Wei Liu
Min Xiao
Yu-Ya Xiao
Shuo Yang
Jian-Yong Zhang
Jing-Jing Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472667

3,105 views
1 citation

Review

Published on 29 Oct 2024

JAK inhibitors: an evidence-based choice of the most appropriate molecule

in Inflammation Pharmacology

Luca Antonioli
Alessandro Armuzzi
Massimo Claudio Fantini
Matteo Fornai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494901

9,724 views
9 citations

Editorial

Published on 28 Oct 2024

Editorial: Epigenetics of inflammatory reactions and pharmacological modulation

in Inflammation Pharmacology

Amedeo Amedei
Cinzia Parolini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505196

1,415 views
1 citation

Review

Published on 25 Oct 2024

Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances

in Inflammation Pharmacology

Feng He
Hongwei Wu
Bin He
Zun Han
Jiayi Chen
Lei Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488036

4,102 views
9 citations

Review

Published on 23 Oct 2024

Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies

in Inflammation Pharmacology

Huiguang Chen
Xuexin Xu
Jingxian Li
Yu Xue
Xin Li
Kaiyu Zhang
Haihui Jiang
Xiaoliu Liu
Mingzhe Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491400

4,859 views
6 citations

Mini Review

Published on 21 Oct 2024

Research progress of knee fibrosis after anterior cruciate ligament reconstruction

in Inflammation Pharmacology

YangYang Liang
QingQing Zhang
YouFei Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493155

4,392 views
1 citation

1,846 articles

articles

Glycyrrhizin as a potential disease-modifying therapy for epilepsy: insights into targeting pyroptosis to exert neuroprotective and anticonvulsant effects

Bacteroides fragilis capsular polysaccharide A ameliorates ulcerative colitis in rat by recovering intestinal barrier integrity and restoring gut microbiota

Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention

Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments

The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses

Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment

Decoding ferroptosis: transforming orthopedic disease management

New insights into SUMOylation and NEDDylation in fibrosis

Editorial: Recent advances in the pathogenesis and potential biomarkers of fibrosis

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid

Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

Estrogen: the forgotten player in metaflammation

P4HA1: an important target for treating fibrosis related diseases and cancer

The impact of diabetes mellitus on tendon pathology: a review

Editorial: Chronic pain: what is the mechanism?

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

JAK inhibitors: an evidence-based choice of the most appropriate molecule

Editorial: Epigenetics of inflammatory reactions and pharmacological modulation

Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances

Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies

Research progress of knee fibrosis after anterior cruciate ligament reconstruction